Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Timber Pharmaceuticals, Inc.Financial_Report.xls
EX-31.1 - CERTIFICATIONS - Timber Pharmaceuticals, Inc.f10q0314ex31i_biopharm.htm
10-Q - QUARTERLY REPORT - Timber Pharmaceuticals, Inc.f10q0314_biopharmxcorp.htm
Exhibit 32.1
Certification Pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Form 10-K of BioPharmX Corporation (the “Company”) for the fiscal quarter ended March 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, in his capacity as an officer of the company, certifies, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 15, 2014
/s/ James Pekarsky
James Pekarsky
Chief Executive Officer, Chief Financial Officer and
Director (Principal Executive Officer, Principal Financial
Officer and Principal Accounting Officer)

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.